Y-Intercept (HK)
TNGX icon

Y-Intercept (HK)’s Tango Therapeutics TNGX Stock Holding History

Y-Intercept (HK)’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.54M Buy
+61,636
New +$1.6M 0.03% 764
2026
Q1 		– Sell
-59,330
Closed -$526K – 2058
2025
Q4 		$526K Buy
59,330
+22,367
+61% +$193K 0.01% 1222
2025
Q3 		$310K Buy
+36,963
New +$250K 0.01% 1370
2022
Q2 		– Sell
-20,305
Closed -$154K – 1191
2022
Q1 		$154K Buy
+20,305
New +$176K 0.04% 646

Other funds holding TNGX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Y-Intercept (HK)'s TNGX Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 61,636 shares worth $1.54M. The stake represents 0.03% of the portfolio and ranks #764 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in TNGX as recently as Q4 2025.

Y-Intercept (HK) first reported a position in TNGX in Q1 2022 and has held it in 4 quarters since. 59 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Y-Intercept (HK) held 61,636 shares of Tango Therapeutics worth $1.54M as of Q3 2026.
  • Tango Therapeutics was a new Y-Intercept (HK) position in Q3 2026.
  • Tango Therapeutics made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #764 holding.
  • Y-Intercept (HK) first reported a position in Tango Therapeutics in Q1 2022 and has held it in 4 quarters since.
  • 59 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.